The Lung Cancer Surgery Market is predicted to reach US$ by 2030 from US$ 5.59 billion in 2021, and to grow at a CAGR of 3.5% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
By Product (Powered Instruments, Hand Instruments, Endosurgical Equipment, and Monitoring or Visualizing Equipment), by Surgery (Robotic Surgery, Thoracotomy, and Minimally Invasive Surgery), by End User (Hospitals, Specialty Care Centers, Ambulatory Surgical Centers)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Accuray Inc., Karl storz SE & Co. KG, Teleflex Incorprotedb, Richard Wolf GMBH, Siemens Healthcare, Intutive Surgical Inc., Boston Scientific Corporation, Angiodynamics, Olympus Corp., Ethicon Endo surgery Inc., Trokamed GmbH, Phoenix Surgical Holdings Limited, Scanlan International Inc., KLS Martin Group, Wexler Surgical Inc. among others
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Lung Cancer Surgery - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Lung Cancer Surgery - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Lung Cancer Surgery - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Lung Cancer Surgery - ANALYSIS & FORECAST, BY REGION
North America Lung Cancer Surgery
1. North America Lung Cancer Surgery , by Country
1. US
2. Canada
1. North America Lung Cancer Surgery , by Product
2. North America Lung Cancer Surgery , by Type
3. North America Lung Cancer Surgery , by Gender
4. North America Lung Cancer Surgery , by Sales Channel
3. Europe Lung Cancer Surgery
1. Europe Lung Cancer Surgery , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Lung Cancer Surgery , by Product
3. Europe Lung Cancer Surgery , by Type
4. Europe Lung Cancer Surgery , by Gender
5. Europe Lung Cancer Surgery , by Sales Channel
4. Asia Pacific Lung Cancer Surgery
1. Asia Pacific Lung Cancer Surgery , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Lung Cancer Surgery , by product
3. Asia Pacific Lung Cancer Surgery , by Type
4. Asia Pacific Lung Cancer Surgery , by Gender
5. Asia Pacific Lung Cancer Surgery , by Sales Channel
5. Rest of the World Lung Cancer Surgery
1. Rest of the World Lung Cancer Surgery , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Lung Cancer Surgery , by Product
3. Rest of the World Lung Cancer Surgery , by Type
4. Rest of the World Lung Cancer Surgery , by Gender
5. Rest of the World Lung Cancer Surgery , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 50